-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Category Archives: Business and Investments
Latest From Business and Investments
Opening Up Innovation
Open Innovation has become a major theme in the life sciences over the last couple of years. Most of the attention has focused on initiatives where big pharma offers access to non-core assets to outside researchers in the hope that they will develop them successfully or form collaborations. In Sweden, AstraZeneca have followed this path, but interest in the concept has spread further down the discovery chain, generating creative initiatives from universities, tech transfer organizations, Read More >
#BIO2013 Company Snapshot: Acreo Swedish ICT
The BIO Business Forum at the International Convention is in full swing! Partnering meetings began at 8:00am this morning, with the first Exhibitor Partnering meetings starting later in the day after the Opening Ceremony. Presentations have also begun. We’ve been highlighting a few presenters in our snapshot campaign, and below is more information on another: Acreo Swedish ICT, a diagnostics and platform technologies company presenting Wednesday at 10:30am in the Chicago Cubs Room. Read more Read More >
Crowdfunding Goes Viral
Is crowdfunding a viable source of capital for biotech companies? μBiome thinks so; they are a startup biotech company that raised $351,193. They asked for $100,000. That’s right; over three times their goal. “[Crowdfunding for biotech] is an idea whose time has come,” says μBiome’s CEO Jessica Richman. “The fact that we did it is proof of that. We’re the first ones but there will be lots of others.” Is there a way that crowdfunding could help Read More >
The Week Ahead for Partnering
As mentioned in our twitter feed, BIO Business Forum and Exhibitor Partnering has surpassed the number of requests in the system over last year’s totals. Over 130,000 partnering meeting requests are off in cyberspace, and close to 22,000 meetings already scheduled. This includes about 4,900 exhibitor partnering meetings, which is another stat beating last year’s numbers. We’ve been excited about the addition of exhibitor partnering, and it’s been great to see the adoption by the exhibitors themselves. Read More >
How BIO Helps Save Biotech Companies Money
We all know that economic conditions and policy can affect the growth rate and sustainability of companies within the biotech industry. Whether a company is seeking an investment deal, creating partnership opportunities, or applying for FDA approval, BIO’s goal is to create avenues that will support the innovation of its member companies. While some folks within the BIO organization focus on BIO’s mission by providing policy, advocacy and communication services, the Business Solutions team, simply Read More >
